used univariate Cox regression analysis to assess the prognostic risk of stage IV CRC patients and predicted that FGF18 was a predictive gene in the risk score model built by the authors to influence the survival difference of stage IV CRC patients (59). This evidence concerns the gene FGF18 and colorectal carcinoma.